Literature DB >> 3706890

Bronchodilator response in chronic obstructive pulmonary disease.

N R Anthonisen, E C Wright.   

Abstract

We measured response to 250 micrograms isoproterenol in 985 patients with COPD who were carefully studied and followed closely for nearly 3 yr. Response was quantitated in relative (% increase in FEV1) and absolute (change in FEV1 as a % predicted normal) terms. Patients were told to abstain from bronchodilator for 6 h before testing, and responses were larger in those who said they had done this. Responses were not related to blood theophylline concentrations. In patients who had abstained for 6 h, response averaged 15% of the baseline FEV1 or 5% of the predicted normal FEV1. Relative response was inversely proportional to baseline FEV1, whereas absolute response was directly related to baseline FEV1. Responses were positively related to symptomatic wheezing and exercise capacity, and negatively to smoking history, but these features accounted for little of the observed variation in response. Patients with large relative and absolute responses demonstrated increased variability of FEV1 with time and a decreased annual rate of decline of FEV1. There was little change in response with time, and the change observed could probably be explained by a gradual decrease in FEV1. However, time-related interindividual and intraindividual variations of response were large and impossible to separate from random variations of FEV1.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3706890

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  36 in total

Review 1.  Stable chronic obstructive pulmonary disease.

Authors:  H A Kerstjens
Journal:  BMJ       Date:  1999-08-21

2.  Measuring bronchodilation in COPD clinical trials.

Authors:  Z L Borrill; C M Houghton; A A Woodcock; J Vestbo; D Singh
Journal:  Br J Clin Pharmacol       Date:  2005-04       Impact factor: 4.335

3.  Efficacy of perioperative administration of long-acting bronchodilator on postoperative pulmonary function and quality of life in lung cancer patients with chronic obstructive pulmonary disease. Preliminary results of a randomized control study.

Authors:  Hidemi Suzuki; Yasuo Sekine; Shigetoshi Yoshida; Makoto Suzuki; Kiyoshi Shibuya; Yuichi Takiguchi; Koichiro Tatsumi; Ichiro Yoshino
Journal:  Surg Today       Date:  2010-09-25       Impact factor: 2.549

Review 4.  Guideline-oriented perioperative management of patients with bronchial asthma and chronic obstructive pulmonary disease.

Authors:  Michiaki Yamakage; Sohshi Iwasaki; Akiyoshi Namiki
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

5.  BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS.

Authors: 
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

6.  Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease.

Authors:  Hironi Makita; Yasuyuki Nasuhara; Katsura Nagai; Yoko Ito; Masaru Hasegawa; Tomoko Betsuyaku; Yuya Onodera; Nobuyuki Hizawa; Masaharu Nishimura
Journal:  Thorax       Date:  2007-06-15       Impact factor: 9.139

7.  Random variation of inspiratory lung function parameters in patients with COPD: a diagnostic accuracy study.

Authors:  Frank J Visser; Sunil Ramlal; Ben Pelzer; P N Richard Dekhuijzen; Yvonne F Heijdra
Journal:  BMC Pulm Med       Date:  2010-05-14       Impact factor: 3.317

8.  Misdiagnosis of patients receiving inhaled therapies in primary care.

Authors:  José Luis Izquierdo; Antonio Martín; Pilar de Lucas; José Miguel Rodríguez-González-Moro; Carlos Almonacid; Alexandra Paravisini
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-08-09

Review 9.  Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studies.

Authors:  Marc Miravitlles; Antonio Anzueto
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-05-07

10.  Effect of bronchodilatation on single breath pulmonary uptake of carbon monoxide in chronic obstructive pulmonary disease.

Authors:  Simonetta Baldi; Claudio Fracchia; Claudio Bruschi; Roberto Dore; Roberto Maestri; Vito Brusasco; Riccardo Pellegrino
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.